News Sentiment

PASW sentiment intelligence

Ping An Biomedical Co., Ltd. news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 49 Balanced news tone 28 relevant articles
Exchange NASDAQ United States
Sector Consumer Cyclical Market context
Industry Textile Manufacturing Read-through group
Latest close 0.16 Week of 10 Jul 2026
Weighted tone 49/100

Balanced news tone

Market reaction Balanced read

News tone and price action are not far from neutral.

Primary event Market update

85/100 classification confidence.

Company focus 28

directly relevant articles

Source quality 0

high-authority source matches

Trend context Trend inactive

-2.0% over one week, -6.2% over four weeks, trend inactive, and near fair-value range.

Latest direct headline Negative

If You Invested $1,000 in Ping An Biomedical (PASW)

Market Reaction

Balanced read

61/100 confidence

News tone and price action are not far from neutral.

Primary event Market update 85/100 classification
One-week reaction -2.0% Price reacting lower
Trend fit Trend inactive -6.2% over four weeks
Fair value -4.4% Near fair-value range

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 4
Neutral 15
Negative 9

Relevance

Why the article matched

Direct first
Direct company coverage 28
Industry context 0
Sector context 0

Sources

Coverage mix

Publishers
Stock Titan 10
Intellectia AI 3
Finviz 2
The Globe and Mail 2
Quiver Quantitative 2
TradingKey 1
Investing.com Nigeria 1
ADVFN 1

Event Lens

What the news is about

Classified themes
Market update 20
Earnings 3
Deals and strategy 3
Balance sheet 1
Macro sensitivity 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-28 of 28
Stock Titan Direct company coverage

If You Invested $1,000 in Ping An Biomedical (PASW)

This article analyzes the historical performance of Ping An Biomedical (PASW) stock, detailing that a $1,000 investment made at its trading inception in October 2025 would now be worth $154, representing an 85% loss. It also provides an overview of the company's business, which i

Tone
Negative 38/100
Event
Market update
Published
08 Jul 2026 01:40
Source
Stock Titan
Finviz Direct company coverage

PASW - Ping An Biomedical Co Ltd Latest SEC Filings

This article provides the latest SEC filings for Ping An Biomedical Co Ltd (PASW), along with detailed financial and stock performance data. It includes information on the company's last close price, percentage change, various financial ratios, insider ownership, and performance

Tone
Negative 39/100
Event
Market update
Published
04 Jul 2026 06:09
Source
Finviz
TradingKey Direct company coverage

Ping An Biomedical Ord Shs

Tone
Neutral 50/100
Event
Market update
Published
18 Jun 2026 09:24
Source
TradingKey
Investing.com Nigeria Direct company coverage

Ping An Biomedical receives Nasdaq extension to regain minimum bid compliance

Ping An Biomedical Co., Ltd. (NASDAQ:BMED) has been granted an additional 180-day extension by Nasdaq to meet the minimum bid price requirement of $1 per share, setting a new deadline of November 23, 2026. The company had previously fallen out of compliance in late 2025 and plans

Tone
Negative 40/100
Event
Market update
Published
01 Jun 2026 06:39
Source
Investing.com Nigeria
Finviz Direct company coverage

PASW - Ping An Biomedical Co Ltd Stock Price and Quote

This page provides detailed stock information for Ping An Biomedical Co Ltd (PASW), including its last close price, percentage change, and key financial metrics. It covers various aspects like market capitalization, P/E ratio, trading volumes, and recent news headlines related to

Tone
Neutral 50/100
Event
Market update
Published
30 May 2026 16:12
Source
Finviz
Stock Titan Direct company coverage

Ping An Biomedical (MJID) granted 180-day Nasdaq extension to fix sub-$1 bid

Ping An Biomedical Co., Ltd. (MJID) has received an additional 180-day extension from Nasdaq, until November 23, 2026, to regain compliance with the minimum $1 bid price requirement. The company's shares have been trading below this threshold, breaching Nasdaq Listing Rule 5550(a

Tone
Neutral 50/100
Event
Market update
Published
29 May 2026 05:10
Source
Stock Titan
The Globe and Mail Direct company coverage

Ping An Biomedical Wins Nasdaq Extension to Regain $1 Minimum Bid Price Compliance

Ping An Biomedical has received an additional 180-day grace period from Nasdaq to regain compliance with the $1 minimum bid price requirement, extending the deadline until November 23, 2026. The company's shares failed to meet this requirement between October 10 and November 20,

Tone
Negative 40/100
Event
Market update
Published
29 May 2026 03:40
Source
The Globe and Mail
ADVFN Direct company coverage

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Ping An Biomedical Co., Ltd. (NASDAQ: PASW) announced two significant developments via a Form 6-K filing on January 12, 2026. Firstly, the company secured strategic investments from several notable investors, including Yao Jinbo of 58 Group, Wang Donghui of Amiba Capital, and Li

Tone
Positive 73/100
Event
Market update
Published
13 Apr 2026 19:40
Source
ADVFN
Meyka Direct company coverage

Ping An Biomedical Co., Ltd. (PASW) Competitors

This article provides a detailed comparison of Ping An Biomedical Co., Ltd. (PASW) with its competitors in the Industrial - Distribution sector. It presents financial metrics such as market cap, P/E ratio, EPS, and dividend yield for PASW and several peer companies. The analysis

Tone
Neutral 50/100
Event
Earnings
Published
08 Apr 2026 17:39
Source
Meyka
Stock Titan Direct company coverage

Ping An Biomedical (PASW) CEO discloses 12.25M indirect share stake on Form 3

Ping An Biomedical Co., Ltd. CEO Liu Pijun has filed an initial statement of beneficial ownership (Form 3), disclosing an indirect holding of 12,250,000 Class A Ordinary Shares through INSPIRETECH LTD. This filing establishes his initial ownership position as both a director and

Tone
Neutral 50/100
Event
Deals and strategy
Published
08 Apr 2026 11:09
Source
Stock Titan
Intellectia AI Direct company coverage

PASW PE Ratio & Valuation, Is PASW Overvalued

This article analyzes the valuation of Ping An Biomedical Co Ltd (PASW), stating it is currently in the "Fair zone" based on its forward PS ratio compared to its five-year average. It discusses various financial metrics such as Price-to-Book (P/B) ratio, Forward Free Cash Flow (F

Tone
Neutral 50/100
Event
Balance sheet
Published
04 Apr 2026 14:39
Source
Intellectia AI
Intellectia AI Direct company coverage

PASW Stock News Today | Earnings, Events & Price Alerts

This article provides recent news and events related to PASW (Ping An Biomedical Co.), including its stock performance and corporate actions. Key updates include shareholder approval for a significant capital structure overhaul, plans to sell 13.61 million ordinary shares, and in

Tone
Positive 64/100
Event
Earnings
Published
04 Apr 2026 12:39
Source
Intellectia AI
Intellectia AI Direct company coverage

PASW Financials: Revenue Breakdown, Margins & Competitor Comparison

This article provides a financial overview of Ping An Biomedical Co Ltd (PASW), detailing its revenue breakdown, profitability margins, and key financial health indicators. It highlights the company's gross margin of 2.78%, operating margin of -43.05%, and net margin of -37.57%,

Tone
Neutral 50/100
Event
Earnings
Published
03 Apr 2026 08:39
Source
Intellectia AI
Stock Titan Direct company coverage

Ping An Biomedical (PASW) director Liu Xianzhi disclosed on Form 3

Ping An Biomedical Co., Ltd. (PASW) director Liu Xianzhi has filed a Form 3, identifying them as a director and reporting person. The filing indicates no insider purchases, sales, or other equity transactions, with zero net insider share transactions and no derivative positions o

Tone
Neutral 50/100
Event
Market update
Published
01 Apr 2026 09:40
Source
Stock Titan
The Manila Times Direct company coverage

All Resolutions Passed at Ping An Biomedical AGM, Clearing Path for Restructured Share Capital

Ping An Biomedical Co., Ltd (NASDAQ: PASW) announced that its shareholders approved all five resolutions at the 2026 Annual General Meeting. These approvals lead to a major restructuring of the company's share capital, including the introduction of high-vote Class B shares, a sha

Tone
Positive 74/100
Event
Market update
Published
23 Mar 2026 01:38
Source
The Manila Times
Stock Titan Direct company coverage

Ping An Biomedical (NASDAQ: PASW) OKs Class B shares and consolidation

Ping An Biomedical shareholders approved a significant capital overhaul, including the creation of high-vote Class B shares and authorization for a future share consolidation. The move targets a specific transaction with major shareholder INSPIRETECH LTD, allowing them to exchang

Tone
Negative 38/100
Event
Market update
Published
19 Mar 2026 15:10
Source
Stock Titan
Stock Titan Direct company coverage

Ping An Bio clears plan to create shares with 100 votes each

Ping An Biomedical (NASDAQ: PASW) shareholders approved all five AGM resolutions on March 18, 2026, authorizing a comprehensive capital restructure. Key actions include increasing authorized capital, creating 100,000,000 Class B shares with 100 votes each, a targeted exchange wit

Tone
Neutral 50/100
Event
Market update
Published
19 Mar 2026 14:10
Source
Stock Titan
Stock Titan Direct company coverage

Ping An Biomedical (PASW) director reports 599,400 indirect shares on Form 3

Ping An Biomedical Co., Ltd. director Liu Qingxian has filed an initial insider ownership report (Form 3) disclosing an indirect ownership of 599,400 Class A Ordinary Shares through SONIC FLASH LIMITED. This filing indicates existing holdings rather than new purchases or sales. T

Tone
Neutral 50/100
Event
Market update
Published
18 Mar 2026 14:08
Source
Stock Titan
Stock Titan Direct company coverage

Ping An Biomedical (PASW) director Gao Jifeng files initial Form 3

Gao Jifeng, a director at Ping An Biomedical Co., Ltd. (PASW), has filed an initial Statement of Beneficial Ownership of Securities (Form 3) with the SEC. The filing, dated March 18, 2026, indicates that Gao Jifeng does not beneficially own any non-derivative or derivative securi

Tone
Neutral 50/100
Event
Market update
Published
18 Mar 2026 14:08
Source
Stock Titan
The Globe and Mail Direct company coverage

Ping An Biomedical Calls March 18 AGM to Approve Dual-Class Shares and Major Share Consolidation

Ping An Biomedical is holding its annual general meeting on March 18, 2026, to vote on significant changes to its capital structure, including the creation of dual-class shares. These changes involve increasing authorized capital to 5 billion ordinary shares, reclassifying most i

Tone
Negative 40/100
Event
Market update
Published
09 Mar 2026 01:38
Source
The Globe and Mail
Quiver Quantitative Direct company coverage

PASW | Ping An Biomedical Co., Stock Data, Price & News

This page provides comprehensive stock data for Ping An Biomedical Co., Ltd. (PASW), including real-time price, financials, insider trading activity, institutional holdings, and news. It also details the company's profile as a Cayman Islands-based holding company operating throug

Tone
Neutral 50/100
Event
Market update
Published
26 Feb 2026 03:52
Source
Quiver Quantitative
Quiver Quantitative Direct company coverage

PASW | Ping An Biomedical Co., Institutional Ownership

This page provides an overview of Ping An Biomedical Co., Ltd. (PASW) institutional ownership and related financial data. It details information such as insider trading activity, institutional and derivative holdings, whale activity, and features like Congress trading, corporate

Tone
Neutral 50/100
Event
Market update
Published
22 Feb 2026 02:52
Source
Quiver Quantitative
Bitget Direct company coverage

According to the latest documents disclosed by the US SEC, up to 13.6 million ordinary shares of Ping An Biomedical Co., Ltd. will be resold by its selling shareholders.

The US SEC has disclosed that selling shareholders of Ping An Biomedical Co., Ltd. plan to resell up to 13.6 million ordinary shares. This significant share resale is expected to affect the company's equity structure, and market analysts are monitoring its potential impact on fut

Tone
Negative 36/100
Event
Market update
Published
13 Feb 2026 05:57
Source
Bitget
Stock Titan Direct company coverage

PASW SEC Filings - Ping An Biomedical 10-K, 10-Q, 8-K Forms

This page provides access to Ping An Biomedical (PASW) SEC filings, including annual 10-K, quarterly 10-Q, and material event 8-K reports, offering detailed insights into the company's financials, operations, and risks. The company operates in both apparel supply chain management

Tone
Negative 40/100
Event
Macro sensitivity
Published
13 Feb 2026 04:52
Source
Stock Titan
Investing.com Canada Direct company coverage

Ping An Biomedical stock plunges after announcing $90 million investment plan By Investing.com

Ping An Biomedical Co., Ltd (NASDAQ:PASW) stock plummeted 31% after announcing a strategic investment plan in Future Biotechnology Group. The plan involves an initial $30 million cash investment and subsequent acquisitions totaling $60 million, dependent on Future Biotechnology G

Tone
Negative 19/100
Event
Deals and strategy
Published
11 Jan 2026 06:58
Source
Investing.com Canada
FinancialContent Direct company coverage

Ping An Biomedical Co., Ltd Announces Strategic Investment in Future Biotechnology Group to Advance Collaborative Development of the Biopharmaceutical Industry

Ping An Biomedical Co., Ltd (NASDAQ: PASW) announced a strategic non-binding investment memorandum with Future Biotechnology Group. The initial investment will be US$30 million in cash, with subsequent acquisitions up to US$60 million combining cash and consideration shares, cont

Tone
Positive 72/100
Event
Deals and strategy
Published
10 Jan 2026 12:32
Source
FinancialContent